Caveolin-1, a novel player in cognitive decline

Aarsland, 2017, Cognitive decline in Parkinson disease, Nat. Rev. Neurol., 13, 217, 10.1038/nrneurol.2017.27 Arnold, 2018, Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums, Nat. Rev. Neurol., 14, 168, 10.1038/nrneurol.2017.185 Arthur, 2016, Projected increase in amyotrophic lateral sclerosis from 2015 to 2040, Nat. Commun., 7, 12408, 10.1038/ncomms12408 Asterholm, 2012, Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1, Cell Metab., 15, 171, 10.1016/j.cmet.2012.01.004 Baake, 2017, Cognitive decline in Huntington’s disease expansion gene carriers, Cortex, 95, 51, 10.1016/j.cortex.2017.07.017 Barbay, 2017, Vascular cognitive impairment: advances and trends, Rev. Neurol. (Paris), 173, 473, 10.1016/j.neurol.2017.06.009 Bastiani, 2010, Caveolae at a glance, J. Cell. Sci., 123, 3831, 10.1242/jcs.070102 Bates, 2015, Huntington disease, Nat. Rev. Dis. Primers, 1, 15005, 10.1038/nrdp.2015.5 Benraiss, 2013, Sustained mobilization of endogenous neural progenitors delays disease progression in a transgenic model of Huntington’s disease, Cell Stem Cell, 12, 787, 10.1016/j.stem.2013.04.014 Bernatchez, 2005, Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides, Proc. Natl. Acad. Sci. U.S.A., 102, 761, 10.1073/pnas.0407224102 Biessels, 2018, Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications, Nat. Rev. Endocrinol., 14, 591, 10.1038/s41574-018-0048-7 Biessels, 2006, Risk of dementia in diabetes mellitus: a systematic review, Lancet Neurol., 5, 64, 10.1016/S1474-4422(05)70284-2 Biessels, 2014, Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions, Lancet Diabetes Endocrinol., 2, 246, 10.1016/S2213-8587(13)70088-3 Bonds, 2019, Depletion of Caveolin-1 in type 2 diabetes model induces alzheimer’s disease pathology precursors, J. Neurosci., 39, 8576, 10.1523/JNEUROSCI.0730-19.2019 Bosch, 2011, Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility, Current biology: CB, 21, 681, 10.1016/j.cub.2011.03.030 Bouillot, 1996, Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties, J. Biol. Chem., 271, 7640, 10.1074/jbc.271.13.7640 Brands, 2005, The effects of type 1 diabetes on cognitive performance: a meta-analysis, Diabetes Care, 28, 726, 10.2337/diacare.28.3.726 Braun, 2000, A novel SNAP25-caveolin complex correlates with the onset of persistent synaptic potentiation, J. Neurosci., 20, 5997, 10.1523/JNEUROSCI.20-16-05997.2000 Brown, 2017, Amyotrophic lateral sclerosis, N. Engl. J. Med., 377, 162, 10.1056/NEJMra1603471 Bucci, 2000, In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation, Nat. Med., 6, 1362, 10.1038/82176 Bucci, 2000, In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation, Nat. Med., 6, 1362, 10.1038/82176 Castellanos, 2018, Low levels of Caveolin-1 predict symptomatic bleeding after thrombolytic therapy in patients with acute ischemic stroke, Stroke, 49, 1525, 10.1161/STROKEAHA.118.020683 Cha, 2015, Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson’s disease, Mol. Neurodegener., 10, 63, 10.1186/s13024-015-0060-5 Chang, 2009, Vascular permeability and pathological angiogenesis in caveolin-1-null mice, Am. J. Pathol., 175, 1768, 10.2353/ajpath.2009.090171 Chang, 2011, Caveolin-1 deletion reduces early brain injury after experimental intracerebral hemorrhage, Am. J. Pathol., 178, 1749, 10.1016/j.ajpath.2010.12.023 Chen, 2010, Caveolin-1 facilitates cyclooxygenase-2 protein degradation, J. Cell. Biochem., 109, 356, 10.1002/jcb.22407 Chen, 2010, Caveolin-1 facilitates cyclooxygenase-2 protein degradation, J. Cell. Biochem., 109, 356, 10.1002/jcb.22407 Chen, 2014, Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species, Free Radic. Biol. Med., 73, 201, 10.1016/j.freeradbiomed.2014.04.029 Chen, 2014, Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species, Free Radic. Biol. Med., 73, 201, 10.1016/j.freeradbiomed.2014.04.029 Chidlow, 2010, Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation, Cardiovasc. Res., 86, 219, 10.1093/cvr/cvq075 Choi, 2016, Regulation of Caveolin-1 expression determines early brain edema after experimental focal cerebral ischemia, Stroke, 47, 1336, 10.1161/STROKEAHA.116.013205 Chornenkyy, 2019, Alzheimer’s disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline, Brain Pathol., 29, 3, 10.1111/bpa.12655 Codrici, 2018, Caveolin-1-Knockout mouse as a model of inflammatory diseases, J. Immunol. Res., 2018, 2498576, 10.1155/2018/2498576 Cohen, 2004, Role of caveolae and caveolins in health and disease, Physiol. Rev., 84, 1341, 10.1152/physrev.00046.2003 Colina, 2016, Membrane raft domains and remodeling in aging brain, Biochimie, 130, 178, 10.1016/j.biochi.2016.08.014 Corti, 2011, What genetics tells us about the causes and mechanisms of Parkinson’s disease, Physiol. Rev., 91, 1161, 10.1152/physrev.00022.2010 Cui, 2018, The role of caveolin-1 in morphine-induced structural plasticity in primary cultured mouse cerebral cortical neurons, Neurosci. Lett., 665, 38, 10.1016/j.neulet.2017.11.033 de Lau, 2006, Epidemiology of Parkinson’s disease, Lancet Neurol., 5, 525, 10.1016/S1474-4422(06)70471-9 De Strooper, 2016, The cellular phase of alzheimer’s disease, Cell, 164, 603, 10.1016/j.cell.2015.12.056 Deary, 2009, Age-associated cognitive decline, Br. Med. Bull., 92, 135, 10.1093/bmb/ldp033 Deng, 2012, The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles, J. Mol. Neurosci., 46, 677, 10.1007/s12031-011-9629-9 Di Meo, 2020, Evolution of the knowledge of free radicals and other oxidants, Oxid. Med. Cell. Longev., 2020, 9829176, 10.1155/2020/9829176 Díaz, 2018, Lipid raft aging" in the human frontal cortex during nonpathological aging: gender influences and potential implications in Alzheimer’s disease, Neurobiol. Aging, 67, 42, 10.1016/j.neurobiolaging.2018.02.022 Dorsey, 2007, Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030, Neurology, 68, 384, 10.1212/01.wnl.0000247740.47667.03 Egawa, 2017, Neuron-specific caveolin-1 overexpression improves motor function and preserves memory in mice subjected to brain trauma, Faseb Journal Official Publication of the Federation of American Societies for Experimental Biology, 10.1096/fj.201601288RRR Egawa, 2017, Neuron-specific caveolin-1 overexpression improves motor function and preserves memory in mice subjected to brain trauma, FASEB J., 31, 3403, 10.1096/fj.201601288RRR Egawa, 2018, Neuron-targeted Caveolin-1 promotes ultrastructural and functional hippocampal synaptic plasticity, Cereb. Cortex, 28, 3255, 10.1093/cercor/bhx196 Esteves, 2019, New insights into the regulatory roles of microRNAs in adult neurogenesis, Curr. Opin. Pharmacol., 50, 38, 10.1016/j.coph.2019.11.003 Eugenia, 2013, Loss of caveolin-1 expression in knock-in mouse model of Huntington’s disease suppresses pathophysiology in vivo, Hum. Mol. Genet., 1, 1 Exner, 2012, Mitochondrial dysfunction in Parkinson’s disease: molecular mechanisms and pathophysiological consequences, EMBO J., 31, 3038, 10.1038/emboj.2012.170 Fallon, 2002, Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain, J. Biol. Chem., 277, 486, 10.1074/jbc.M109806200 Farooq, 2017, Pharmacotherapy for vascular cognitive impairment, CNS Drugs, 31, 759, 10.1007/s40263-017-0459-3 Feng, 1999, VEGF-induced permeability increase is mediated by caveolae, Invest. Ophthalmol. Vis. Sci., 40, 157 Feng, 2010, Caveolin-1 protects against sepsis by modulating inflammatory response, alleviating bacterial burden, and suppressing thymocyte apoptosis, J. Biol. Chem., 285, 25154, 10.1074/jbc.M110.116897 Feng, 2012, Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae, J. Cell. Physiol., 227, 2480, 10.1002/jcp.22984 Feng, 2013, Role of caveolin-1 and caveolae signaling in endotoxemia and sepsis, Life Sci., 93, 1, 10.1016/j.lfs.2013.05.016 Fjell, 2014, What is normal in normal aging? Effects of aging, amyloid and Alzheimer’s disease on the cerebral cortex and the hippocampus, Prog. Neurobiol., 117, 20, 10.1016/j.pneurobio.2014.02.004 Fortin, 2004, Lipid rafts mediate the synaptic localization of alpha-synuclein, J. Neurosci., 24, 6715, 10.1523/JNEUROSCI.1594-04.2004 Francesconi, 2009, Regulation of group I metabotropic glutamate receptor trafficking and signaling by the caveolar/lipid raft pathway, J. Neurosci., 29, 3590, 10.1523/JNEUROSCI.5824-08.2009 Francesconi, 2009, Regulation of group I metabotropic glutamate receptor trafficking and signaling by the Caveolar/Lipid raft pathway, Journal of Neuroscience the Official Journal of the Society for Neuroscience, 29, 3590, 10.1523/JNEUROSCI.5824-08.2009 Gao, 2014, Treadmill exercise promotes angiogenesis in the ischemic penumbra of rat brains through caveolin-1/VEGF signaling pathways, Brain Res., 1585, 83, 10.1016/j.brainres.2014.08.032 García-Cardeña, 1997, Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo, J. Biol. Chem., 272, 25437, 10.1074/jbc.272.41.25437 Gaudreault, 2004, Increased caveolin-1 expression in Alzheimer’s disease brain, Neurobiol. Aging, 25, 753, 10.1016/j.neurobiolaging.2003.07.004 Gaudreault, 2005, A role for caveolin-1 in post-injury reactive neuronal plasticity, J. Neurochem., 92, 831, 10.1111/j.1471-4159.2004.02917.x Gaudreault, 2005, A role for caveolin-1 in post-injury reactive neuronal plasticity, J. Neurochem., 92, 831, 10.1111/j.1471-4159.2004.02917.x George PM, 2015, Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments, Neuron, 87, 297, 10.1016/j.neuron.2015.05.041 Gorelick, 2011, Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association, Stroke, 42, 2672, 10.1161/STR.0b013e3182299496 Gorelick, 2016, Vascular cognitive impairment and dementia, Biochim. Biophys. Acta, 1862, 860, 10.1016/j.bbadis.2015.12.015 Grassi, 2019, LIPID RAFTS AND NEURODEGENERATION: structural and functional roles in physiologic aging and neurodegenerative diseases, J. Lipid Res. Gu, 2011, Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts blood-brain barrier permeability, Front. Biosci. Schol. Ed. (Schol Ed), 3, 1216, 10.2741/222 Gu, 2012, Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury, J. Neurochem., 120, 147, 10.1111/j.1471-4159.2011.07542.x Gupta, 2019, Alteration in memory cognition due to activation of caveolin-1 and oxidative damage in a model of dementia of Alzheimer’s type, Indian J. Pharmacol., 51, 173, 10.4103/ijp.IJP_81_17 Haddad, 2020, Role of Caveolin-1 in diabetes and its complications, Oxid. Med. Cell. Longev., 2020, 9761539, 10.1155/2020/9761539 Hatano, 2007, Leucine-rich repeat kinase 2 associates with lipid rafts, Hum. Mol. Genet., 16, 678, 10.1093/hmg/ddm013 Head, 2008, Caveolin-1 expression is essential for N-methyl-D-aspartate receptor-mediated Src and extracellular signal-regulated kinase 1/2 activation and protection of primary neurons from ischemic cell death, Faseb Journal Official Publication of the Federation of American Societies for Experimental Biology, 22, 828, 10.1096/fj.07-9299com Head, 2010, Loss of caveolin-1 accelerates neurodegeneration and aging, PLoS One, 5, e15697, 10.1371/journal.pone.0015697 Head, 2011, Neuron-targeted caveolin-1 protein enhances signaling and promotes arborization of primary neurons, J. Biol. Chem., 286, 33310, 10.1074/jbc.M111.255976 Head, 2014, Interaction of membrane/lipid rafts with the cytoskeleton: impact on signaling and function: membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling, Biochim. Biophys. Acta, 1838, 532, 10.1016/j.bbamem.2013.07.018 Head, 2021, Insel PA neuron-targeted Caveolin-1 protein enhances signaling and promotes arborization of primary neurons, J. Biol. Chem., 286, 33310, 10.1074/jbc.M111.255976 Hebert, 2000, Vascular dementia : incidence and risk factors in the Canadian study of health and aging, Stroke, 31, 1487, 10.1161/01.STR.31.7.1487 Henstridge, 2018, Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis, Acta Neuropathol., 135, 213, 10.1007/s00401-017-1797-4 Hering, 2003, Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability, J. Neurosci., 23, 3262, 10.1523/JNEUROSCI.23-08-03262.2003 Herzer, 2016, Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease, Acta Neuropathol. Commun., 4, 103, 10.1186/s40478-016-0354-z Hiromura, 2017, Caveolin-1, a binding protein of CD26, is essential for the anti-inflammatory effects of dipeptidyl peptidase-4 inhibitors on human and mouse macrophages, Biochem. Biophys. Res. Commun. Hou, 2019, Ageing as a risk factor for neurodegenerative disease, Nat. Rev. Neurol., 15, 565, 10.1038/s41582-019-0244-7 Hu, 2008, Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury, Am. J. Physiol. Lung Cell Mol. Physiol., 294, 178, 10.1152/ajplung.00263.2007 Huang, 2012, Cerebralcare Granule® attenuates blood-brain barrier disruption after middle cerebral artery occlusion in rats, Exp. Neurol., 237, 453, 10.1016/j.expneurol.2012.07.017 Huang, 2018, A review of the role of cav-1 in neuropathology and neural recovery after ischemic stroke, J. Neuroinflammation, 15, 348, 10.1186/s12974-018-1387-y Hugo, 2014, Dementia and cognitive impairment: epidemiology, diagnosis, and treatment, Clin. Geriatr. Med., 30, 421, 10.1016/j.cger.2014.04.001 International Diabetes Federation, 2019 Jiao, 2013, Caveolin-1 Tyr14 phosphorylation induces interaction with TLR4 in endothelial cells and mediates MyD88-Dependent signaling and sepsis-induced lung inflammation, J. Immunol., 191, 6191, 10.4049/jimmunol.1300873 Joe, 2019, Cognitive symptoms of Alzheimer’s disease: clinical management and prevention, Bmj, 367, l6217, 10.1136/bmj.l6217 Ju, 1997, Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity, J. Biol. Chem., 272, 18522, 10.1074/jbc.272.30.18522 Kagawa, 2015, Fatty acid-binding protein 7 regulates function of caveolae in astrocytes through expression of caveolin-1, Glia, 63, 780, 10.1002/glia.22784 Kalia, 2015, Parkinson’s disease, Lancet (London, England), 386, 896, 10.1016/S0140-6736(14)61393-3 Kalia, 2016, Parkinson disease in 2015: evolving basic, pathological and clinical concepts in PD, Nat. Rev. Neurol., 12, 65, 10.1038/nrneurol.2015.249 Kang, 2006, Caveolin-1 upregulation in senescent neurons alters amyloid precursor protein processing, Exp. Mol. Med., 38, 126, 10.1038/emm.2006.16 Kang, 2021, Caveolin-1 upregulation in senescent neurons alters amyloid precursor protein processing, Exp. Mol. Med., 38, 126, 10.1038/emm.2006.16 Kassan, 2016, Caveolin-1 regulation of Disrupted-in-Schizophrenia-1 as a potential therapeutic target for schizophrenia, J. Neurophysiol., 117, 10.1152/jn.00481.2016 Kiernan, 2017, Amyotrophic lateral sclerosis, Lancet (London, England), 390, 2084, 10.1016/S0140-6736(17)31287-4 Kim, 2013, DJ-1 associates with lipid rafts by palmitoylation and regulates lipid rafts-dependent endocytosis in astrocytes, Hum. Mol. Genet., 22, 4805, 10.1093/hmg/ddt332 Kim, 2021, Park SM DJ-1 deficiency impairs glutamate uptake into astrocytes via the regulation of flotillin-1 and caveolin-1 expression, Sci. Rep., 6, 28823, 10.1038/srep28823 Klimova, 2017, Cognitive decline in normal aging and its prevention: a review on non-pharmacological lifestyle strategies, Clin. Interv. Aging, 12, 903, 10.2147/CIA.S132963 Knowland, 2014, Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke, Neuron, 82, 603, 10.1016/j.neuron.2014.03.003 Koekkoek, 2015, Cognitive function in patients with diabetes mellitus: guidance for daily care, Lancet Neurol., 14, 329, 10.1016/S1474-4422(14)70249-2 Koudinov, 2005, Cholesterol homeostasis failure as a unifying cause of synaptic degeneration, J. Neurol. Sci., 229-230, 233, 10.1016/j.jns.2004.11.036 Lamport, 2009, Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review, Neurosci. Biobehav. Rev., 33, 394, 10.1016/j.neubiorev.2008.10.008 Li, 2015, Effect of caveolin-1 on the expression of tight junction-associated proteins in rat glioma-derived microvascular endothelial cells, Int. J. Clin. Exp. Pathol., 8, 13067 Liu, 2002, Caveolin-1 expression enhances endothelial capillary tubule formation, J. Biol. Chem., 277, 10661, 10.1074/jbc.M110354200 Lo, 2017, The borderland between normal aging and dementia, Ci ji yi xue za zhi = Tzu-chi medical journal, 29, 65 Long, 2019, Alzheimer disease: an update on pathobiology and treatment strategies, Cell, 179, 312, 10.1016/j.cell.2019.09.001 Lu, 2019, Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis, J. Neurol. Lu, 2020, Aerobic and resistance training enhances endothelial progenitor cell function via upregulation of caveolin-1 in mice with type 2 diabetes, Stem Cell Res. Ther., 11, 10, 10.1186/s13287-019-1527-z Makoto, 2003, α-Synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson’s disease, J. Neurochem. Mandyam, 2017, Neuron-targeted Caveolin-1 improves molecular signaling, plasticity, and behavior dependent on the Hippocampus in adult and aged mice, Biol. Psychiatry, 81, 101, 10.1016/j.biopsych.2015.09.020 Mansour, 2018, A refined model of chronic cerebral hypoperfusion resulting in cognitive impairment and a low mortality rate in rats, J. Neurosurg., 131, 892, 10.3171/2018.3.JNS172274 Maren, 2013, The contextual brain: implications for fear conditioning, extinction and psychopathology, Nat. Rev. Neurosci., 14, 417, 10.1038/nrn3492 Matos de Araújo, 2020, Hypothalamic IRX3: a new player in the development of obesity, Trends Endocrinol. Metab., 31, 368, 10.1016/j.tem.2020.01.002 Mauch, 2001, CNS synaptogenesis promoted by glia-derived cholesterol, Science, 294, 1354, 10.1126/science.294.5545.1354 Mayor, 2014, Diabetes in midlife increases cognitive decline 20 years later, study finds, Bmj, 349, g7386, 10.1136/bmj.g7386 McColgan, 2018, Huntington’s disease: a clinical review, Eur. J. Neurol., 25, 24, 10.1111/ene.13413 Mesa-Herrera, 2019, Lipid and lipid raft alteration in aging and neurodegenerative diseases: a window for the development of new biomarkers, Int. J. Mol. Sci., 20, 10.3390/ijms20153810 Michel, 1997, Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin, J. Biol. Chem., 272, 15583, 10.1074/jbc.272.25.15583 Mikol, 2002, Schwann cell caveolin-1 expression increases during myelination and decreases after axotomy, Glia, 38, 191, 10.1002/glia.10063 Mirza, 2010, Caveolin-1 deficiency dampens Toll-like receptor 4 signaling through eNOS activation, Am. J. Pathol., 176, 2344, 10.2353/ajpath.2010.091088 Montuschi, 2015, Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy, J. Neurol. Neurosurg. Psychiatr., 86, 168, 10.1136/jnnp-2013-307223 Moon, 2015, Mitochondrial dysfunction in parkinson’s disease, Exp. Neurobiol., 24, 103, 10.5607/en.2015.24.2.103 Nasri, 2015, Antioxidant plants and diabetes mellitus, J. Res. Med. Sci., 20, 491, 10.4103/1735-1995.163977 Niesman, 2013, Caveolin isoform switching as a molecular, structural, and metabolic regulator of microglia, Mol. Cell. Neurosci., 56, 283, 10.1016/j.mcn.2013.07.002 Niesman, 2014, Traumatic brain injury enhances neuroinflammation and lesion volume in caveolin deficient mice, J. Neuroinflammation, 11, 39, 10.1186/1742-2094-11-39 Nuytemans, 2010, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Hum. Mutat., 31, 763, 10.1002/humu.21277 Nyberg, 2014, Structural plasticity of the brain to psychostimulant use, Neuropharmacology, 87, 115, 10.1016/j.neuropharm.2014.07.004 Ohnuma, 2006, T-cell activation via CD26 and caveolin-1 in rheumatoid synovium, Mod. Rheumatol., 16, 3, 10.3109/s10165-005-0452-4 Pan, 2006, Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells, Acta Pharmacol. Sin., 27, 1567, 10.1111/j.1745-7254.2006.00462.x Pang, 2017, Role of caveolin-1/vascular endothelial growth factor pathway in basic fibroblast growth factor-induced angiogenesis and neurogenesis after treadmill training following focal cerebral ischemia in rats, Brain Res., 1663, 9, 10.1016/j.brainres.2017.03.012 Pang, 2017, Role of caveolin-1/vascular endothelial growth factor pathway in basic fibroblast growth factor-induced angiogenesis and neurogenesis after treadmill training following focal cerebral ischemia in rats, Brain Res., 1663, 9, 10.1016/j.brainres.2017.03.012 Parat, 2009, The biology of caveolae: achievements and perspectives, Int. Rev. Cell Mol. Biol., 273, 117, 10.1016/S1937-6448(08)01804-2 Parat, 2012, Caveolin-1, caveolae, and glioblastoma, Neurooncology, 14, 679 Park, 2000, Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells, J. Biol. Chem., 275, 20847, 10.1074/jbc.M908162199 Park, 2003, Caveolin-1 null (-/-) mice show dramatic reductions in life span, Biochemistry, 42, 15124, 10.1021/bi0356348 Paul, 2018, Accumulation of cholesterol and homocysteine in the nigrostriatal pathway of brain contributes to the dopaminergic neurodegeneration in mice, Neuroscience, 388, 347, 10.1016/j.neuroscience.2018.07.041 Peffer, 2014, Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells, Mol. Cell. Biol., 34, 2611, 10.1128/MCB.01121-13 Phillips, 2004, Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface, Am. J. Physiol. Lung Cell Mol. Physiol., 286, 1055, 10.1152/ajplung.00262.2003 Phukan, 2012, The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study, J. Neurol. Neurosurg. Psychiatr., 83, 102, 10.1136/jnnp-2011-300188 Rabin, 2017, Subjective cognitive decline in preclinical alzheimer’s disease, Annu. Rev. Clin. Psychol., 13, 369, 10.1146/annurev-clinpsy-032816-045136 Roger, 2011, Heart disease and stroke statistics--2011 update: a report from the American Heart Association, Circulation, 123, e18, 10.1161/CIR.0b013e3182009701 Rosell, 2013, Factors secreted by endothelial progenitor cells enhance neurorepair responses after cerebral ischemia in mice, PLoS One, 8, e73244, 10.1371/journal.pone.0073244 Sachdev, 2004, The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients, Neurology, 62, 912, 10.1212/01.WNL.0000115108.65264.4B Saiki, 2012, Molecular pathogenesis of Parkinson’s disease: update, J. Neurol. Neurosurg. Psychiatr., 83, 430, 10.1136/jnnp-2011-301205 Sawada, 2019, Neuron-targeted caveolin-1 improves neuromuscular function and extends survival in an SOD1 G93A mice, Faseb J., 10.1096/fj.201802652RR Sawada, 2019, Neuron-targeted caveolin-1 improves neuromuscular function and extends survival in SOD1 mice, FASEB J., 33, 7545, 10.1096/fj.201802652RR Shao, 2020, Cav-1 ablation in pancreatic stellate cells promotes pancreatic Cancer growth through Nrf2-Induced shh signaling, Oxid. Med. Cell. Longev., 2020, 1868764, 10.1155/2020/1868764 Shen, 2006, Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury, J. Neurochem., 96, 1078, 10.1111/j.1471-4159.2005.03589.x Shen, 2008, Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells, J. Neurochem., 107, 478, 10.1111/j.1471-4159.2008.05630.x Shiroto, 2014, Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium, PLoS One, 9, e87871, 10.1371/journal.pone.0087871 Shiroto, 2014, Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium, PLoS One, 9, e87871, 10.1371/journal.pone.0087871 Shivshankar, 2014, Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction, J. Mol. Cell. Cardiol., 76, 84, 10.1016/j.yjmcc.2014.07.020 Silvestri, 2005, Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism, Hum. Mol. Genet., 14, 3477, 10.1093/hmg/ddi377 Sindi, 2015, Advances in the prevention of alzheimer’s disease, F1000Prime Rep., 7, 50, 10.12703/P7-50 Smart, 1996, A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane, J. Biol. Chem., 271, 29427, 10.1074/jbc.271.46.29427 Smith, 2017, Clinical presentations and epidemiology of vascular dementia, Clin. Sci., 131, 1059, 10.1042/CS20160607 Sonnino, 2014, Lipid rafts in neurodegeneration and neuroprotection, Mol. Neurobiol., 50, 130, 10.1007/s12035-013-8614-4 Sonveaux, 2004, Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis, Circ. Res., 95, 154, 10.1161/01.RES.0000136344.27825.72 Sun, 2016, Curcumin attenuates high glucose-induced podocyte apoptosis by regulating functional connections between caveolin-1 phosphorylation and ROS, Acta Pharmacol. Sin., 37, 645, 10.1038/aps.2015.159 Sun, 2017, Curcumin decreases hyperphosphorylation of tau by down-regulating Caveolin-1/GSK-3beta in N2a/APP695swe cells and APP/PS1 double transgenic alzheimer’s disease mice, Am. J. Chin. Med. (Gard City N Y), 45, 1667, 10.1142/S0192415X17500902 Surguchov, 2020, Caveolin: a new link between diabetes and AD, Cell. Mol. Neurobiol., 10.1007/s10571-020-00796-4 Svenningsson, 2012, Cognitive impairment in patients with Parkinson’s disease: diagnosis, biomarkers, and treatment, Lancet Neurol., 11, 697, 10.1016/S1474-4422(12)70152-7 Tahir, 2009, Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells, Cancer Biol. Ther., 8, 2286, 10.4161/cbt.8.23.10138 Takayasu, 2010, Caveolin-1 knockout mice exhibit impaired induction of mGluR-dependent long-term depression at CA3-CA1 synapses, Proc. Natl. Acad. Sci. U.S.A., 107, 21778, 10.1073/pnas.1015553107 Tan, 2003, Nerve growth factor blocks the glucose-induced down-regulation of caveolin-1 expression in Schwann cells via p75 neurotrophin receptor signaling, J. Biol. Chem., 278, 23151, 10.1074/jbc.M212986200 Trushina, 2006, Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo, Hum. Mol. Genet., 15, 3578, 10.1093/hmg/ddl434 Tu, 2017, Angiogenic effects of apigenin on endothelial cells after hypoxia-reoxygenation via the caveolin-1 pathway, Int. J. Mol. Med., 40, 1639 Tysnes, 2017, Epidemiology of Parkinson’s disease, J. Neural Transm. Vienna (Vienna), 124, 901, 10.1007/s00702-017-1686-y van der Kant, 2020, Amyloid-β-independent regulators of tau pathology in Alzheimer disease, Nat. Rev. Neurosci., 21, 21, 10.1038/s41583-019-0240-3 Vardjan, 2017, Astrocytic pathological calcium homeostasis and impaired vesicle trafficking in neurodegeneration, Int. J. Mol. Sci., 18, 10.3390/ijms18020358 Vassilieva, 2009, Flotillin-1 stabilizes caveolin-1 in intestinal epithelial cells, Biochem. Biophys. Res. Commun., 379, 460, 10.1016/j.bbrc.2008.12.118 Venkat, 2015, Models and mechanisms of vascular dementia, Exp. Neurol., 272, 97, 10.1016/j.expneurol.2015.05.006 Volonte, 2002, Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts, Mol. Biol. Cell, 13, 2502, 10.1091/mbc.01-11-0529 Volonte, 2016, Caveolin-1 controls mitochondrial function through regulation of m-AAA mitochondrial protease, Aging, 8, 2355, 10.18632/aging.101051 von Bernhardi, 2017, What Is Neural Plasticity?, Adv. Exp. Med. Biol., 1015, 1, 10.1007/978-3-319-62817-2_1 Wang, 2006, Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway, Am. J. Respir. Cell Mol. Biol., 34, 434, 10.1165/rcmb.2005-0376OC Wang, 2017, Caveolin-1: an oxidative stress-related target for Cancer prevention, Oxid. Med. Cell. Longev., 2017, 7454031, 10.1155/2017/7454031 Wang, 2019, Caveolin-1 phosphorylation is essential for axonal growth of human neurons derived from iPSCsImage_1.JPEGImage_2.TIFF, Front. Cell. Neurosci., 13, 10.3389/fncel.2019.00324 Wang, 2020, TBRG4 silencing promotes progression of squamous cell carcinoma via regulation of CAV-1 expression and ROS formation, Cell. Mol. Biol. (Noisy-le-grand), 66, 157, 10.14715/cmb/2020.66.2.26 Weiss, 2013 WHO, 2019 Wu, 2017, High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: a potential molecular mechanism for diabetes-induced cognitive dysfunction, Oncotarget, 8, 40843, 10.18632/oncotarget.17257 Xie, 2018, Inhibition of transient receptor potential vanilloid 4 decreases the expressions of caveolin-1 and caveolin-2 after focal cerebral ischemia and reperfusion in rats, Neuropathology, 10.1111/neup.12469 Xie, 2019, Treadmill exercise ameliorates focal cerebral ischemia/reperfusion-induced neurological deficit by promoting dendritic modification and synaptic plasticity via upregulating caveolin-1/VEGF signaling pathways, Exp. Neurol., 313, 60, 10.1016/j.expneurol.2018.12.005 Xu, 2001, The key role of caveolin-1 in estrogen-mediated regulation of endothelial nitric oxide synthase function in cerebral arterioles in vivo, J. Cereb. Blood Flow Metab., 21, 907, 10.1097/00004647-200108000-00002 Yang, 2015, Increased coupling of caveolin-1 and estrogen receptor α contributes to the fragile X syndrome, Ann. Neurol., 77, 618, 10.1002/ana.24358 Yongjuan, 2019, Axin-1 binds to Caveolin-1 to regulate the LPS-induced inflammatory response in AT-I cells, Biochem. Biophys. Res. Commun. Yu, 2008, Hyperglycemia and downregulation of caveolin-1 enhance neuregulin-induced demyelination, Glia, 56, 877, 10.1002/glia.20662 Yu DM, 2017, Caveolin-1 deficiency induces premature senescence with mitochondrial dysfunction, Aging Cell Yu DM, 2017, Caveolin-1 deficiency induces premature senescence with mitochondrial dysfunction, Aging Cell, 16, 773, 10.1111/acel.12606 Yue, 2021 Yujun, 2019, SPIONs enhances IL-10-producing macrophages to relieve sepsis via Cav1-Notch1/HES1-mediated autophagy, Int. J. Nanomedicine, 14, 6779, 10.2147/IJN.S215055 Yun, 2011, Caveolin-1 is involved in reactive oxygen species-induced SHP-2 activation in astrocytes, Exp. Mol. Med., 43, 660, 10.3858/emm.2011.43.12.075 Yun, 2011, Caveolin-1 is involved in reactive oxygen species-induced SHP-2 activation in astrocytes, Exp. Mol. Med., 43, 660, 10.3858/emm.2011.43.12.075 Zhang, 2010, Effects of green tea polyphenols on caveolin-1 of microvessel fragments in rats with cerebral ischemia, Neurol. Res., 32, 963, 10.1179/016164110X12700393823570 Zhang, 2017, Caveolin-1 protects retinal ganglion cells against acute ocular hypertension injury via modulating microglial phenotypes and distribution and activating AKT pathway, Sci. Rep., 7, 10716, 10.1038/s41598-017-10719-x Zhang, 2020, Cav-1 (Caveolin-1) deficiency increases autophagy in the endothelium and attenuates vascular inflammation and atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 40, 1510, 10.1161/ATVBAHA.120.314291 Zhao, 2009, Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration, J. Clin. Invest., 119, 2009, 10.1172/JCI33338 Zhao, 2015, Tanshinone II A, a multiple target neuroprotectant, promotes caveolae-dependent neuronal differentiation, Eur. J. Pharmacol., 765, 437, 10.1016/j.ejphar.2015.09.006 Zhao, 2017, Treadmill exercise promotes neurogenesis in ischemic rat brains via Caveolin-1/VEGF signaling pathways, Neurochem. Res., 42, 389, 10.1007/s11064-016-2081-z Zhu, 2018, Magnesium reduces blood-brain barrier permeability and regulates amyloid-beta transcytosis, Mol. Neurobiol., 55, 7118, 10.1007/s12035-018-0896-0 Zi, 2018, The autophagic degradation of Cav-1 contributes to PA-induced apoptosis and inflammation of astrocytes, Cell Death Dis., 9, 771, 10.1038/s41419-018-0795-3 Zou, 2015, Electroacupuncture pretreatment attenuates blood‑brain barrier disruption following cerebral ischemia/reperfusion, Mol. Med. Rep., 12, 2027, 10.3892/mmr.2015.3672